A Risk Stratification System in Myeloma Patients with Autologous Stem Cell Transplantation

A Risk Stratification System in Myeloma Patients with Autologous Stem Cell Transplantation

Autologous stem cell transplantation (ASCT) has been a mainstay in myeloma treatment for over three decades, but patient prognosis post-ASCT varies significantly. In a retrospective study of 5259 patients with multiple myeloma (MM) at the University of Arkansas for Medical Sciences undergoing ASCT w...

Full description

Bibliographic Details
Main Authors: Wancheng Guo, Christopher Strouse, David Mery, Eric R. Siegel, Manit N. Munshi, Timothy Cody Ashby, Yan Cheng, Fumou Sun, Visanu Wanchai, Zijun Zhang, Clyde Bailey, Daisy V. Alapat, Hongling Peng, Samer Al Hadidi, Sharmilan Thanendrarajan, Carolina Schinke, Maurizio Zangari, Frits van Rhee, Guido Tricot, John D. Shaughnessy, Fenghuang Zhan
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Cancers
Subjects:
multiple myeloma
autologous stem cell transplantation
prognosis
Online Access:https://www.mdpi.com/2072-6694/16/6/1116

Internet

https://www.mdpi.com/2072-6694/16/6/1116

Similar Items